DBC1は,SIRT1のネガティブレギュラーである
Ja-Eun Kim1, Junjie Chen, Zhenkun Lou
1Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut 06520, USA.
Nature
|February 1, 2008
まとめ
Deleted in Breast Cancer-1 (DBC1) は,SIRT1の活動を直接抑制し,これは老化と癌に関連したタンパク質です. DBC1を減少させると,SIRT1を強化する.
科学分野:
- 分子生物学は分子生物学である.
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
背景:
- NADに依存するタンパク質脱酸化酵素Sir2 (静かな情報調節体2) は,生物の寿命を調節するために不可欠です.
- SIRT1は酵母Sir2の哺乳類の同型であり,様々な細胞機能と潜在的に腫瘍発生に役割を果たしています.
- SIRT1の細胞の役割はよく研究されているが,その活動調節はあまり理解されていない.
研究 の 目的:
- SIRT1活動の規制メカニズムを調査する.
- SIRT1機能と相互作用し,それを調節するタンパク質を特定する.
- 老化と癌におけるSIRT1調節の影響を調査する.
主な方法:
- 同免疫プレシピテーションアッセイは,DBC1とSIRT1.1の間のタンパク質複合体の形成を検出するためのアッセイです.
- SIRT1デセチラゼの活性を測定するためのインビトロおよびインビボアッセイ.
- DBC1発現を低調化する遺伝子サイレンシング技術 (siRNAなど)
- 遺伝子毒性ストレス後のアポトーシス誘導の分析.
主要な成果:
- Deleted in Breast Cancer-1 (DBC1) は,SIRT1.1と安定した複合体を形成しています.
- DBC1はSIRT1の活性と直接相互作用し,SIRT1の活性をインビトロとインビボの両方で抑制します.
- DBC1発現のダウンレギュレーションは,遺伝子毒性ストレスによって誘発されたアポトーシスのSIRT1媒介阻害を強化します.
結論:
- DBC1は,SIRT1活動の直接的負の調節剤として作用する.
- これらの発見は,SIRT1.1の調節に関する新しい洞察を提供します.
- DBC1とSIRT1の相互作用は,老化と癌の根底にある分子機構を理解する上で重要な意味を持つ.
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
01:23Negative Regulator Molecules
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...